Gene Expression Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation), By Product (Kits & Reagents, DNA Chips, Others), By Capacity (Low- to Mid- Plex, High-Plex), By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others), By Technique (RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis), By Region and Competition, 2020-2030F
The Global Gene Expression Market, valued at USD 15.78 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 21.86 Billion by 2030. Gene expression delineates the fundamental cellular process whereby genetic information from DNA is converted into functional gene products, primarily proteins or RNA molecules, thereby dictating specific cellular attributes and functions. The market's expansion is significantly propelled by continuous advancements in genomic research and sequencing technologies, the escalating global incidence of chronic and infectious diseases necessitating precise diagnostic and prognostic tools, and growing investments in biopharmaceutical research and development for novel therapeutic discovery.
Key Market Drivers
The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.
Key Market Challenges
A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.
Key Market Trends
The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.
Key Market Players
In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.
Available Customizations:
Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The global gene expression market is significantly influenced by continued advancements in genomics and biotechnology, which serve as foundational catalysts for innovation. These developments encompass sophisticated sequencing technologies, refined gene editing tools such as CRISPR, and comprehensive omics approaches, all of which enhance the depth and efficiency of gene expression analysis. This continuous evolution in scientific capabilities enables researchers to explore complex biological systems with unprecedented resolution, driving the discovery of new therapeutic targets and diagnostic biomarkers.
Key Market Challenges
A significant challenge impeding the growth of the Global Gene Expression Market is the substantial capital outlay required for advanced analysis platforms. Implementing high-throughput sequencing technologies and establishing complex bioinformatics infrastructure necessitates considerable upfront investment. This financial burden restricts broader adoption, particularly among smaller research entities, emerging biotechnology firms, and academic laboratories operating with limited budgets. Such high initial and ongoing maintenance costs can delay or prevent these organizations from acquiring essential equipment and developing the necessary expertise, thereby hindering the widespread application of gene expression technologies across various research and clinical domains.
Key Market Trends
The expansion of spatial transcriptomics significantly advances gene expression analysis by offering critical contextual information, enabling visualization of gene activity within its native tissue microenvironment. This capability is essential for unraveling intricate disease mechanisms, identifying precise therapeutic targets, and discovering biomarkers. Spatial transcriptomics provides insights into cellular heterogeneity and cell-to-cell interactions, fostering notable market growth. For instance, in June 2024, Moleculent AB secured USD 25.0 million in Series A financing to advance its spatial mapping of cell-cell communication. This development is supported by broader industry investment, with the European Federation of Pharmaceutical Industries and Associations reporting an estimated €50,000 million invested in research and development in Europe in 2023.
Key Market Players
- Catalent, Inc.
- Quest Diagnostics Incorporated
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Luminex Corporation
- Takara Bio USA, Inc.
- Danaher Corporation
In this report, the Global Gene Expression Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Gene Expression Market, By Process:
- Sample Collection
- Purification
- cDNA synthesis & conversion
- PCR Analysis
- Data analysis & interpretation
- Gene Expression Market, By Product:
- Kits & Reagents
- DNA Chips
- Others
- Gene Expression Market, By Capacity:
- Low- to Mid- Plex
- High-Plex
- Gene Expression Market, By Application:
- Drug Discovery & Development
- Clinical Diagnostics
- Biotech & Microbiology
- Others
- Gene Expression Market, By Technique:
- RNA Expression
- Promoter Analysis
- Protein Expression& Posttranslational Modification Analysis
- Gene Expression Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Gene Expression Market.
Available Customizations:
Global Gene Expression Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL GENE EXPRESSION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA GENE EXPRESSION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Process
6.2.2. By Product
6.2.3. By Capacity
6.2.4. By Application
6.2.5. By Technique
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Expression Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Process
6.3.1.2.2. By Product
6.3.1.2.3. By Capacity
6.3.1.2.4. By Application
6.3.1.2.5. By Technique
6.3.2. Canada Gene Expression Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Process
6.3.2.2.2. By Product
6.3.2.2.3. By Capacity
6.3.2.2.4. By Application
6.3.2.2.5. By Technique
6.3.3. Mexico Gene Expression Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Process
6.3.3.2.2. By Product
6.3.3.2.3. By Capacity
6.3.3.2.4. By Application
6.3.3.2.5. By Technique
7. EUROPE GENE EXPRESSION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Process
7.2.2. By Product
7.2.3. By Capacity
7.2.4. By Application
7.2.5. By Technique
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Expression Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Process
7.3.1.2.2. By Product
7.3.1.2.3. By Capacity
7.3.1.2.4. By Application
7.3.1.2.5. By Technique
7.3.2. France Gene Expression Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Process
7.3.2.2.2. By Product
7.3.2.2.3. By Capacity
7.3.2.2.4. By Application
7.3.2.2.5. By Technique
7.3.3. United Kingdom Gene Expression Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Process
7.3.3.2.2. By Product
7.3.3.2.3. By Capacity
7.3.3.2.4. By Application
7.3.3.2.5. By Technique
7.3.4. Italy Gene Expression Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Process
7.3.4.2.2. By Product
7.3.4.2.3. By Capacity
7.3.4.2.4. By Application
7.3.4.2.5. By Technique
7.3.5. Spain Gene Expression Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Process
7.3.5.2.2. By Product
7.3.5.2.3. By Capacity
7.3.5.2.4. By Application
7.3.5.2.5. By Technique
8. ASIA PACIFIC GENE EXPRESSION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Process
8.2.2. By Product
8.2.3. By Capacity
8.2.4. By Application
8.2.5. By Technique
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gene Expression Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Process
8.3.1.2.2. By Product
8.3.1.2.3. By Capacity
8.3.1.2.4. By Application
8.3.1.2.5. By Technique
8.3.2. India Gene Expression Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Process
8.3.2.2.2. By Product
8.3.2.2.3. By Capacity
8.3.2.2.4. By Application
8.3.2.2.5. By Technique
8.3.3. Japan Gene Expression Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Process
8.3.3.2.2. By Product
8.3.3.2.3. By Capacity
8.3.3.2.4. By Application
8.3.3.2.5. By Technique
8.3.4. South Korea Gene Expression Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Process
8.3.4.2.2. By Product
8.3.4.2.3. By Capacity
8.3.4.2.4. By Application
8.3.4.2.5. By Technique
8.3.5. Australia Gene Expression Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Process
8.3.5.2.2. By Product
8.3.5.2.3. By Capacity
8.3.5.2.4. By Application
8.3.5.2.5. By Technique
9. MIDDLE EAST & AFRICA GENE EXPRESSION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Process
9.2.2. By Product
9.2.3. By Capacity
9.2.4. By Application
9.2.5. By Technique
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gene Expression Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Process
9.3.1.2.2. By Product
9.3.1.2.3. By Capacity
9.3.1.2.4. By Application
9.3.1.2.5. By Technique
9.3.2. UAE Gene Expression Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Process
9.3.2.2.2. By Product
9.3.2.2.3. By Capacity
9.3.2.2.4. By Application
9.3.2.2.5. By Technique
9.3.3. South Africa Gene Expression Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Process
9.3.3.2.2. By Product
9.3.3.2.3. By Capacity
9.3.3.2.4. By Application
9.3.3.2.5. By Technique
10. SOUTH AMERICA GENE EXPRESSION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Process
10.2.2. By Product
10.2.3. By Capacity
10.2.4. By Application
10.2.5. By Technique
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gene Expression Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Process
10.3.1.2.2. By Product
10.3.1.2.3. By Capacity
10.3.1.2.4. By Application
10.3.1.2.5. By Technique
10.3.2. Colombia Gene Expression Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Process
10.3.2.2.2. By Product
10.3.2.2.3. By Capacity
10.3.2.2.4. By Application
10.3.2.2.5. By Technique
10.3.3. Argentina Gene Expression Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Process
10.3.3.2.2. By Product
10.3.3.2.3. By Capacity
10.3.3.2.4. By Application
10.3.3.2.5. By Technique
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL GENE EXPRESSION MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Catalent, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Quest Diagnostics Incorporated
15.3. F. Hoffmann-La Roche Ltd
15.4. Illumina, Inc.
15.5. PerkinElmer, Inc.
15.6. Thermo Fisher Scientific, Inc.
15.7. Promega Corporation
15.8. Luminex Corporation
15.9. Takara Bio USA, Inc.
15.10. Danaher Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL GENE EXPRESSION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Process (Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation)
5.2.2. By Product (Kits & Reagents, DNA Chips, Others)
5.2.3. By Capacity (Low- to Mid- Plex, High-Plex)
5.2.4. By Application (Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others)
5.2.5. By Technique (RNA Expression, Promoter Analysis, Protein Expression& Posttranslational Modification Analysis)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTH AMERICA GENE EXPRESSION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Process
6.2.2. By Product
6.2.3. By Capacity
6.2.4. By Application
6.2.5. By Technique
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Expression Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Process
6.3.1.2.2. By Product
6.3.1.2.3. By Capacity
6.3.1.2.4. By Application
6.3.1.2.5. By Technique
6.3.2. Canada Gene Expression Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Process
6.3.2.2.2. By Product
6.3.2.2.3. By Capacity
6.3.2.2.4. By Application
6.3.2.2.5. By Technique
6.3.3. Mexico Gene Expression Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Process
6.3.3.2.2. By Product
6.3.3.2.3. By Capacity
6.3.3.2.4. By Application
6.3.3.2.5. By Technique
7. EUROPE GENE EXPRESSION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Process
7.2.2. By Product
7.2.3. By Capacity
7.2.4. By Application
7.2.5. By Technique
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Expression Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Process
7.3.1.2.2. By Product
7.3.1.2.3. By Capacity
7.3.1.2.4. By Application
7.3.1.2.5. By Technique
7.3.2. France Gene Expression Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Process
7.3.2.2.2. By Product
7.3.2.2.3. By Capacity
7.3.2.2.4. By Application
7.3.2.2.5. By Technique
7.3.3. United Kingdom Gene Expression Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Process
7.3.3.2.2. By Product
7.3.3.2.3. By Capacity
7.3.3.2.4. By Application
7.3.3.2.5. By Technique
7.3.4. Italy Gene Expression Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Process
7.3.4.2.2. By Product
7.3.4.2.3. By Capacity
7.3.4.2.4. By Application
7.3.4.2.5. By Technique
7.3.5. Spain Gene Expression Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Process
7.3.5.2.2. By Product
7.3.5.2.3. By Capacity
7.3.5.2.4. By Application
7.3.5.2.5. By Technique
8. ASIA PACIFIC GENE EXPRESSION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Process
8.2.2. By Product
8.2.3. By Capacity
8.2.4. By Application
8.2.5. By Technique
8.2.6. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gene Expression Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Process
8.3.1.2.2. By Product
8.3.1.2.3. By Capacity
8.3.1.2.4. By Application
8.3.1.2.5. By Technique
8.3.2. India Gene Expression Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Process
8.3.2.2.2. By Product
8.3.2.2.3. By Capacity
8.3.2.2.4. By Application
8.3.2.2.5. By Technique
8.3.3. Japan Gene Expression Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Process
8.3.3.2.2. By Product
8.3.3.2.3. By Capacity
8.3.3.2.4. By Application
8.3.3.2.5. By Technique
8.3.4. South Korea Gene Expression Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Process
8.3.4.2.2. By Product
8.3.4.2.3. By Capacity
8.3.4.2.4. By Application
8.3.4.2.5. By Technique
8.3.5. Australia Gene Expression Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Process
8.3.5.2.2. By Product
8.3.5.2.3. By Capacity
8.3.5.2.4. By Application
8.3.5.2.5. By Technique
9. MIDDLE EAST & AFRICA GENE EXPRESSION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Process
9.2.2. By Product
9.2.3. By Capacity
9.2.4. By Application
9.2.5. By Technique
9.2.6. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gene Expression Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Process
9.3.1.2.2. By Product
9.3.1.2.3. By Capacity
9.3.1.2.4. By Application
9.3.1.2.5. By Technique
9.3.2. UAE Gene Expression Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Process
9.3.2.2.2. By Product
9.3.2.2.3. By Capacity
9.3.2.2.4. By Application
9.3.2.2.5. By Technique
9.3.3. South Africa Gene Expression Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Process
9.3.3.2.2. By Product
9.3.3.2.3. By Capacity
9.3.3.2.4. By Application
9.3.3.2.5. By Technique
10. SOUTH AMERICA GENE EXPRESSION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Process
10.2.2. By Product
10.2.3. By Capacity
10.2.4. By Application
10.2.5. By Technique
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gene Expression Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Process
10.3.1.2.2. By Product
10.3.1.2.3. By Capacity
10.3.1.2.4. By Application
10.3.1.2.5. By Technique
10.3.2. Colombia Gene Expression Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Process
10.3.2.2.2. By Product
10.3.2.2.3. By Capacity
10.3.2.2.4. By Application
10.3.2.2.5. By Technique
10.3.3. Argentina Gene Expression Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Process
10.3.3.2.2. By Product
10.3.3.2.3. By Capacity
10.3.3.2.4. By Application
10.3.3.2.5. By Technique
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL GENE EXPRESSION MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Catalent, Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Quest Diagnostics Incorporated
15.3. F. Hoffmann-La Roche Ltd
15.4. Illumina, Inc.
15.5. PerkinElmer, Inc.
15.6. Thermo Fisher Scientific, Inc.
15.7. Promega Corporation
15.8. Luminex Corporation
15.9. Takara Bio USA, Inc.
15.10. Danaher Corporation
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER